has not been definitively enrollment process, offer therapies are not advisable. Database current as of, https://www.ssa.gov/benefits/medicare/prescriptionhelp.html, https://www.cms.gov/files/document/2022-announcement.pdf, https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf, DUP.23.01.0314 Last Update: March 2023, DUP.22.11.0007 Last Update: December 2022, DUP.23.01.0070 Last Update: February 2023, DUP.22.03.0194 Last Update: August 2022, DUP.22.03.0291 Last Update: July 2022, DUP.22.05.0386 Last Update: September 2022, Moderate-to-Severe Eczema (Ages 6+ Months), Moderate-to-Severe Asthma (Ages 6+ Years), Chronic Rhinosinusitis with Nasal Polyposis, Uncontrolled moderate-to-severe eosinophilic or oral steroid, https://mothertobaby.org/ongoing-study/dupixent/, https://www.census.gov/content/dam/census/library/publications/2017/demo/p60-260.pdf, https://www.bcbsm.com/index/health-insurance-help/faqs/plan-types/health-spending-accounts/fsa.html, Whether you have prescription drug insurance, Whether your insurance provider considers the medication to be preferred or not preferred. Key points of contact for coverage are located on the card itself. Sanofi US is hosting this website on behalf of Sanofi and Regeneron Pharmaceuticals, Inc. This is typical for a specialty drug like DUPIXENT. Both companies may independently process your personal data to manage patient support programs and product marketing campaigns. If you have enrolled inDUPIXENT MyWay, you will receive a welcome call from a nurse educator while your insurance benefits are being confirmed. Whether youre considering treatment with DUPIXENT or youre a DUPIXENT patient or caregiver, you can sign up for emails and additional resources from DUPIXENT MyWay that can help you: Uncontrolled moderate-to-severe eosinophilic or oral steroid dependent asthma, Uncontrolled chronic rhinosinusitis with nasal polyposis. Your healthcare provider may send you to an ophthalmologist for an eye exam if needed. For more financial assistance information, dial 1844DUPIXENT ( 1-844-387-4936), option 1 Remember to monitor and document the patients progress for reauthorization. Part D is included in most Medicare Advantage (Part C) plans and can be added separately if you have Original Medicare (Parts A and B).9. estimate my income in conjunction with the Patient Assistance Program eligibility determination process, if . household income, to qualify. Extra Help with Medicare Prescription Drug Costs. Lastly, the specialty pharmacy reviews the prescription and contacts the patient to arrange for payment and delivery. Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT. There are several reasons for this, including incomplete documentation, administrative errors, clinical reasons or a no-coverage determination, or a plan exclusion. DUPIXENT MyWay Patient Support Program Available at https://aspe.hhs.gov/poverty-guidelines. DUPIXENT is not used to treat sudden breathing problems. Accessed 01/18/23. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Some plans, including commercial and Medicare, may even have a separate pharmacy benefit card. You should not receive a live vaccine right before and during treatment with DUPIXENT. If you have any other questions, DUPIXENT MyWay can help you understand the process. Atopic Dermatitis: DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Words To Describe Mediterranean Food,
How Much Do Amish Charge To Build A House,
Articles D